Stellenwert der Lungenmetastasenchirurgie beim metastasierenden Nierenzellkarzinom

Translated title of the contribution: Value of pulmonary resection for metastatic renal carcinoma

S. Piltz, G. Meimarakis, M. Wichmann, R. Hatz

Research output: Contribution to journalReview articlepeer-review


The clinical value of pulmonary resection for metastatic renal carcinoma has been documented. In selected patients, 5- and 10-year survival rates vary between 35-45% and 10-30%, respectively. As expected in solid carcinomas, curative resection of the lesions is the most significant factor for long-term survival. Furthermore, the number of lesions, size, and malignant lymphatic involvement are considered to be of prognostic influence. The importance of the disease-free interval is still under discussion. The use of minimally invasive procedures, e.g., video-assisted thoracoscopic surgery and radiofrequency ablation, does not provide sufficient curative resection. Manual palpation following thoracotomy allows detection of additional metastases in 30-60% of the patients. Thus, these minimal procedures are only permissible within controlled clinical studies.

Translated title of the contributionValue of pulmonary resection for metastatic renal carcinoma
Original languageGerman
Pages (from-to)950-958
Number of pages9
Issue number9
Publication statusPublished - Sept 2004
Externally publishedYes


  • Lung metastases
  • Prognostic factors
  • Radiofrequency ablation
  • Renal cell carcinoma
  • Survival


Dive into the research topics of 'Value of pulmonary resection for metastatic renal carcinoma'. Together they form a unique fingerprint.

Cite this